resveratrol has been researched along with Hypertension, Malignant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grujić-Milanović, J; Ivanov, M; Jaćević, V; Jovović, D; Karanović, D; Mihailović-Stanojević, N; Milanović, SD; Miloradović, Z; Vajić, UJ | 1 |
| Grujić-Milanović, J; Jaćević, V; Jovović, D; Mihailović-Stanojević, N; Milanović, SD; Miloradović, Z; Milosavljević, I | 1 |
2 other study(ies) available for resveratrol and Hypertension, Malignant
| Article | Year |
|---|---|
Resveratrol improved kidney function and structure in malignantly hypertensive rats by restoration of antioxidant capacity and nitric oxide bioavailability.
Topics: Animals; Antioxidants; Biological Availability; Blood Pressure; Hypertension; Hypertension, Malignant; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Resveratrol | 2022 |
Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Body Weight; Cardiotonic Agents; Female; Heart Ventricles; Hemodynamics; Hypertension, Malignant; Inflammation; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Oxidation-Reduction; Rats, Inbred SHR; Resveratrol; Thiobarbituric Acid Reactive Substances | 2021 |